| Cheryl Lynn Beighle, MD | |
|
4420 76th St Ne, Marysville, WA 98270-3726 | |
| (360) 651-7492 | |
| (360) 651-7482 |
| Full Name | Cheryl Lynn Beighle |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 4420 76th St Ne, Marysville, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629046206 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 24058 (Washington) | Primary |
| Entity Name | The Everett Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831186766 PECOS PAC ID: 6406752153 Enrollment ID: O20031211000922 |
News Archive
Mylan Inc. today announced that it has entered into a facility agreement with a syndicate of banks to securitize up to $300 million of U.S. accounts receivable. The facility is committed and has a maturity of three years. The interest rate on any outstanding borrowings will be more than 100 basis points lower than the rate on the company's secured credit facilities.
The Washington Post: "In its latest long-term forecast, the nonpartisan Congressional Budget Office predicted that the national debt, which has surged to nearly 60 percent of annual economic output in the wake of the recession, would continue rising in the coming decades despite cost-containment measures in the health overhaul Obama signed this spring.
Footstar, Inc. announced today that certain of its subsidiaries have entered into a definitive merger agreement with CPEX Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, in a transaction valued at approximately $76.6 million, plus fees and expenses relating to the transaction.
Abbott has announced that it has received U.S. Food and Drug Administration (FDA) approval to market HUMIRA (adalimumab) as a treatment to reduce signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in patients four years of age and older.
A study published online in Nature Methods today demonstrated that Droplet Digital PCR (ddPCR-) technology can be used to precisely and reproducibly quantify microRNA (miRNA) in plasma and serum across different days, paving the way for further development of miRNA and other nucleic acids as circulating biomarkers.
› Verified 7 days ago
| Entity Name | Providence Health & Services-wa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336390442 PECOS PAC ID: 0648330787 Enrollment ID: O20090106000737 |
News Archive
Mylan Inc. today announced that it has entered into a facility agreement with a syndicate of banks to securitize up to $300 million of U.S. accounts receivable. The facility is committed and has a maturity of three years. The interest rate on any outstanding borrowings will be more than 100 basis points lower than the rate on the company's secured credit facilities.
The Washington Post: "In its latest long-term forecast, the nonpartisan Congressional Budget Office predicted that the national debt, which has surged to nearly 60 percent of annual economic output in the wake of the recession, would continue rising in the coming decades despite cost-containment measures in the health overhaul Obama signed this spring.
Footstar, Inc. announced today that certain of its subsidiaries have entered into a definitive merger agreement with CPEX Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, in a transaction valued at approximately $76.6 million, plus fees and expenses relating to the transaction.
Abbott has announced that it has received U.S. Food and Drug Administration (FDA) approval to market HUMIRA (adalimumab) as a treatment to reduce signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in patients four years of age and older.
A study published online in Nature Methods today demonstrated that Droplet Digital PCR (ddPCR-) technology can be used to precisely and reproducibly quantify microRNA (miRNA) in plasma and serum across different days, paving the way for further development of miRNA and other nucleic acids as circulating biomarkers.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cheryl Lynn Beighle, MD Po Box 5127, Everett, WA 98206-5127 Ph: () - | Cheryl Lynn Beighle, MD 4420 76th St Ne, Marysville, WA 98270-3726 Ph: (360) 651-7492 |
News Archive
Mylan Inc. today announced that it has entered into a facility agreement with a syndicate of banks to securitize up to $300 million of U.S. accounts receivable. The facility is committed and has a maturity of three years. The interest rate on any outstanding borrowings will be more than 100 basis points lower than the rate on the company's secured credit facilities.
The Washington Post: "In its latest long-term forecast, the nonpartisan Congressional Budget Office predicted that the national debt, which has surged to nearly 60 percent of annual economic output in the wake of the recession, would continue rising in the coming decades despite cost-containment measures in the health overhaul Obama signed this spring.
Footstar, Inc. announced today that certain of its subsidiaries have entered into a definitive merger agreement with CPEX Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, in a transaction valued at approximately $76.6 million, plus fees and expenses relating to the transaction.
Abbott has announced that it has received U.S. Food and Drug Administration (FDA) approval to market HUMIRA (adalimumab) as a treatment to reduce signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in patients four years of age and older.
A study published online in Nature Methods today demonstrated that Droplet Digital PCR (ddPCR-) technology can be used to precisely and reproducibly quantify microRNA (miRNA) in plasma and serum across different days, paving the way for further development of miRNA and other nucleic acids as circulating biomarkers.
› Verified 7 days ago
Dr. Sarah Eva Bergman Lewis, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2901 174th St Ne, Marysville, WA 98271 Phone: 360-454-1900 | |
Sophia Shiau, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 4420 76th St Ne, Marysville, WA 98270 Phone: 360-651-7492 Fax: 360-651-7482 | |
Michael Su, Pediatrics Medicare: Medicare Enrolled Practice Location: 2901 174th St Ne, Marysville, WA 98271 Phone: 360-454-1900 Fax: 360-454-1991 | |
Denise Shushan, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 4420 76th St Ne, Marysville, WA 98270 Phone: 360-651-7482 Fax: 360-651-7482 | |
Minkyung Shin, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4420 76th St Ne, Marysville, WA 98270 Phone: 360-651-7492 Fax: 360-651-7482 | |
Shirley Chen, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 4420 76th St Ne, Marysville, WA 98270 Phone: 360-651-7492 Fax: 360-651-7482 |